Evaluating the Long-Term Health Economic Implications of Improving the Proportion of Patients with Type 2 Diabetes Meeting Treatment Targets in Mexico Barnaby Hunt, MSc, José Luis Aguilar Garza, PhD, Carlos Jesús Enríquez Vázquez, MD, Pavika Jain, MSc, William J. Valentine, PhD Value in Health Regional Issues Volume 8, Pages 20-27 (December 2015) DOI: 10.1016/j.vhri.2015.01.001 Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Fig. 1 Value in Health Regional Issues 2015 8, 20-27DOI: (10.1016/j.vhri.2015.01.001) Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Fig. 2 Value in Health Regional Issues 2015 8, 20-27DOI: (10.1016/j.vhri.2015.01.001) Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Fig. 3 Value in Health Regional Issues 2015 8, 20-27DOI: (10.1016/j.vhri.2015.01.001) Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Fig. 4 Value in Health Regional Issues 2015 8, 20-27DOI: (10.1016/j.vhri.2015.01.001) Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Fig. 5 Value in Health Regional Issues 2015 8, 20-27DOI: (10.1016/j.vhri.2015.01.001) Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Fig. 6 Value in Health Regional Issues 2015 8, 20-27DOI: (10.1016/j.vhri.2015.01.001) Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions